APM News & Events

Aptorum Group, DiamiR Biosciences, and Instant NanoBiosensors announced a collaboration between DiamiR and INB to validate INB's automated APOE testing platform for clinical use in DiamiR's CLIA-certified, CAP-accredited clinical laboratory. Tony Chung, Chairman of Instant NanoBiosensors, stated, "We view DiamiR Biosciences as a highly respected reference laboratory. We believe that completing this validation and implementing the service together will strengthen confidence in the INB platform, expand DiamiR's validated service offerings, and establish a strong foundation for future collaboration and additional applications beyond APOE testing."

Aptorum Group files $75M mixed securities shelf

The company will not receive any proceeds from the sale of shares of Class A Common Stock by the selling securityholders.

Aptorum Group announced that it has entered into definitive agreements for the purchase and sale of 1M Class A ordinary shares at a purchase price of $2.00 per share in a registered direct offering. In a concurrent private placement, the company will issue unregistered warrants to purchase up to 2M Class A ordinary shares at an exercise price of $2.00 per share that will be exercisable upon issuance and will expire twenty-four months from the effective date of a registration statement registering for resale the ordinary shares underlying the warrants. The closing of the offering is expected to occur on or about October 14, subject to the satisfaction of customary closing conditions. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.